Hypnosis in Interventional Electrophysiology (PAINLESS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03250871 |
Recruitment Status :
Completed
First Posted : August 16, 2017
Last Update Posted : February 10, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Hypnosis has already shown to decrease pain and anxiety in different surgical specialities. Nevertheless, its input has never been studied in cardiology. This research is a prospective, monocentric, controlled and randomized study.
Patients over 18 years old and hospitalized for atrial flutter ablation may be included and randomized into one of the arms: placebo or hypnosis.
Global pain will be assessed by a visual analogue pain scale. Anxiety, morphine consumption, and patient sedation will also be assessed.
The aim of this study is to improve the care given to patient undergoing atrial flutter ablation.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Flutter, Atrial Over 18 Years Old | Other: Hypnosis Other: Placebo | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 116 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Supportive Care |
Official Title: | Hypnosis Contribution to Interventional Electrophysiology Performed Under Local Anesthesia and Morphine Titration Study PAINLESS : Does Hypnosis Reduce Pain in Electrophysiology Procedures ? |
Actual Study Start Date : | October 2, 2017 |
Actual Primary Completion Date : | September 23, 2019 |
Actual Study Completion Date : | September 26, 2019 |
Arm | Intervention/treatment |
---|---|
Placebo Comparator: Placebo
Placebo will be the suggestion of self-relaxation methods (for example, "try to relax" ,"try to think of pleasant moment ") and the diffusion of "white noise" during surgery.
|
Other: Placebo
Placebo consists in non-hypnotic relaxation suggestions and in hearing white noise through headphones |
Experimental: Hypnosis
Hypnosis will be associated with the usual anesthesia. Hypnosis is a temporary modification of consciousness technique based on suggestion. It is divided into three phases:
|
Other: Hypnosis
Hypnosis will be supervised by a nurse trained by the French Institute of Hypnosis. |
- Global pain self-assessment during the procedure [ Time Frame: Collected 45 min after the procedure ]Assessed with visual analogue pain scale
- Anxiety during the procedure [ Time Frame: Collected after the procedure ]Visual analog scale self-assessment
- Morphine consumption [ Time Frame: Collected after the procedure ]milligram
- Patient sedation evaluation [ Time Frame: Collected after the procedure ]numerical rating scale; Externally assessed by the electrophysiologist
- Pain assessed prospectively during the procedure; [ Time Frame: Evaluated every 5 minutes during the procedure; ]Numerical rating scale score

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Over 18 years old
- Surgery ablation of atrial flutter
- Agreement to participate of the study
Exclusion Criteria:
- Person who does not speak French or deaf
- Chronic pain with the visual analogue scale > 5
- Psychiatric pathology
- Contraindication to paracetamol, lidocaine, morphine
- Pregnant women, or breast-feeding women or without effective contraception

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03250871
France | |
CHU DE Poitiers | |
Poitiers, France |
Responsible Party: | Poitiers University Hospital |
ClinicalTrials.gov Identifier: | NCT03250871 |
Other Study ID Numbers: |
2017-A01936-47 |
First Posted: | August 16, 2017 Key Record Dates |
Last Update Posted: | February 10, 2020 |
Last Verified: | December 2019 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Atrial Flutter Arrhythmias, Cardiac Heart Diseases Cardiovascular Diseases Pathologic Processes |